⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 16, 2026
The Dispatch

NSE

Anlon Healthcare LimitedAHCL

Anlon Healthcare Limited is an Indian pharmaceutical company focused on the manufacturing and distribution of healthcare products.

Key productsPharmaceuticals, medical devices
GeographyIndia, with regional presence in Southeast Asia
CompetitorsCadila Healthcare, Dr. Reddy's Laboratories

AI-generated overview — verify before relying on it.

Net institutional flow

−₹19.3 Cr

Institutional buyers

5 in / 7 out

High-impact filings

0 · tilt Neutral

Next corporate action

Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share

ex 2026-04-24

Competitive landscape — the read

vs most-traded names
Institutional money is backing MTNL hardest (+₹41.3 Cr net). AHCL ranks #6 of 7 on flow (net selling −₹19.3 Cr).
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1MTNL+₹41.3 Cr331————
2ATALREAL+₹7.4 Cr363————
3GATECH+₹0.4 Cr298————
4IRMENERGY−₹2.2 Cr356————
5QUADFUTURE−₹9 Cr571————
6AHCLThis−₹19.3 Cr33————
7MOBIKWIK−₹150.9 Cr975————

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

SWOT

Weaknesses

  • • [object Object]
  • • [object Object]

Opportunities

  • • [object Object]
  • • [object Object]

Threats

  • • [object Object]
  • • [object Object]

AI-generated from our data — verify before relying on it.

Timeline — AHCL day by day

  1. 2026-06-11FilingAnlon Healthcare Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (LODR) ReUpdates
  2. 2026-06-09BulkSELL · ₹14.4 CrNEOMILE GROWTH FUND-SERIES I
  3. 2026-06-09FilingAnlon Healthcare Limited has informed the Exchange regarding Media Interaction of Chairman & Managing DirectorManagement
  4. 2026-06-09FilingAnlon Healthcare Limited has informed the Exchange about TranscriptInvestor Call
  5. 2026-04-24BulkSELL · ₹3.4 CrNEOMILE GROWTH FUND-SERIES I
  6. 2026-04-24ActionFace Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per ShareSplit
  7. 2026-04-24ActionBonus 1:1Bonus
  8. 2026-01-21BulkSELL · ₹5.1 CrNEOMILE CORPORATE ADVISORY LIMITED
  9. 2026-01-21BulkBUY · ₹5 CrNEOMILE GROWTH FUND-SERIES I
  10. 2025-11-10BulkSELL · ₹6.5 CrNEOMILE CORPORATE ADVISORY LIMITED
  11. 2025-11-04BulkSELL · ₹9.9 CrNEOMILE CORPORATE ADVISORY LIMITED
  12. 2025-11-03BulkSELL · ₹23.7 CrNEOMILE CORPORATE ADVISORY LIMITED
  13. 2025-11-03BulkBUY · ₹12.8 CrNEOMILE GROWTH FUND - SERIES I
  14. 2025-09-24BulkBUY · ₹4.2 CrRP FAMILY PRIVATE TRUST
  15. 2025-09-19BulkBUY · ₹3.4 CrHRTI PRIVATE LIMITED
  16. 2025-09-19BulkSELL · ₹3.6 CrHRTI PRIVATE LIMITED
  17. 2025-09-19BulkSELL · ₹3.5 CrMATHISYS ADVISORS LLP
  18. 2025-09-19BulkBUY · ₹3.8 CrMATHISYS ADVISORS LLP
  19. 2025-09-19BulkBUY · ₹6.8 CrRP FAMILY PRIVATE TRUST
  20. 2025-09-18BulkSELL · ₹6.8 CrHRTI PRIVATE LIMITED
  21. 2025-09-18BulkBUY · ₹7.2 CrHRTI PRIVATE LIMITED
  22. 2025-09-18BulkSELL · ₹4.5 CrMATHISYS ADVISORS LLP
  23. 2025-09-18BulkBUY · ₹4.5 CrMATHISYS ADVISORS LLP
  24. 2025-09-17BulkSELL · ₹4.2 CrHRTI PRIVATE LIMITED
  25. 2025-09-17BulkBUY · ₹5 CrHRTI PRIVATE LIMITED
  26. 2025-09-11BulkBUY · ₹7.8 CrNEOMILE CORPORATE ADVISORY LIMITED
  27. 2025-09-10BulkSELL · ₹3.6 CrNEOMILE CORPORATE ADVISORY LIMITED
  28. 2025-09-10BulkBUY · ₹7.2 CrNEOMILE CORPORATE ADVISORY LIMITED
  29. 2025-09-09BulkSELL · ₹1.5 CrNEOMILE CORPORATE ADVISORY LIMITED
  30. 2025-09-09BulkBUY · ₹7.9 CrNEOMILE CORPORATE ADVISORY LIMITED
  31. 2025-09-03BulkBUY · ₹6.4 CrASCENT WEALTH
  32. 2025-09-03BulkBUY · ₹18.4 CrNEOMILE CORPORATE ADVISORY LIMITED
  33. 2025-09-03BulkBUY · ₹18.2 CrNEOMILE GROWTH FUND - SERIES I
  34. 2025-09-03BulkSELL · ₹14.4 CrNOVA GLOBAL OPPORTUNITIES FUND PCC - TOUCHSTONE
  35. 2025-09-03BulkSELL · ₹8.2 CrPINE OAK GLOBAL FUND - CLASS B
  36. 2025-09-03BulkSELL · ₹6.7 CrRELIGO COMMODITIES VENTURES FUND
  37. 2025-09-03BulkSELL · ₹10.5 CrSUNRISE INVESTMENT OPPORTUNITIES FUND
  38. 2025-09-03BulkBUY · ₹4.6 CrTRADE CORNER

Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.

Filings that matter

  • 2
    UpdatesNeutral

    Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 Invitation for TV Interview on NDTV Profit.'.

    Source PDF →
  • 4
    ManagementNeutral

    Media Interaction of Chairman & Managing Director.

    Source PDF →
  • 2
    Investor CallNeutral

    Transcript

    Source PDF →

Bulk & block deals

1M3M6M1Y2YAll

33 deals · 2025-09-03 → 2026-06-09

DateCounterpartyInvestor typeSideValue
2026-06-09NEOMILE GROWTH FUND-SERIES IInstitutionSELL₹14.4 Cr
2026-04-24NEOMILE GROWTH FUND-SERIES IInstitutionSELL₹3.4 Cr
2026-01-21NEOMILE CORPORATE ADVISORY LIMITEDInstitutionSELL₹5.1 Cr
2026-01-21NEOMILE GROWTH FUND-SERIES IInstitutionBUY₹5 Cr
2025-11-10NEOMILE CORPORATE ADVISORY LIMITEDInstitutionSELL₹6.5 Cr
2025-11-04NEOMILE CORPORATE ADVISORY LIMITEDInstitutionSELL₹9.9 Cr
2025-11-03NEOMILE CORPORATE ADVISORY LIMITEDInstitutionSELL₹23.7 Cr
2025-11-03NEOMILE GROWTH FUND - SERIES IInstitutionBUY₹12.8 Cr
2025-09-24RP FAMILY PRIVATE TRUSTInstitutionBUY₹4.2 Cr
2025-09-19HRTI PRIVATE LIMITEDProp / churnBUY₹3.4 Cr

33 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

Results & transcripts

Financial results

None yet.

News & chatter on AHCL

RSS News

0

No recent news.

Google News RSS — links open the source.

The Dispatch

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.